BioSpace News Archive

It doesn’t happen that often, but Merck’s checkpoint inhibitor Keytruda received a rejection from the U.S. Food and Drug Administration.

Virginia, which is part of the BioSpace Hotbed region known as BioCapital, is home to an $8 billion biopharma market that employs more than 26,545 people.

It is planned to go into operation in 2021, and is expected to create more than 200 new jobs in Lee County, North Carolina.

The Phase II trial did not meet its primary endpoint.

Hector Armando Kellum, a former senior executive with the Novartis subsidiary Sandoz, pleaded guilty for his role in a price-fixing scheme for generic drugs developed by his company.

It was discovered in Lake Pampulha, an artificial lake in Belo Horizonte, a city in Brazil, and infects amoeba.

Frank Reynolds, the founder and chief executive officer of PixarBio, was also ordered to repay $7.5 million to investors who backed the company’s non-opioid painkiller, NeuroRelease.

To date, there are more than 72,000 confirmed and suspected cases of COVID-19 and 1,023 deaths from COVID-19, most in mainland China.

Feb. 19, 2020 12:30 UTC Investment to Accelerate Molecular Diagnostic Product Selection, Development and Accessibility WALTHAM, Mass.--( BUSINESS WIRE )-- Scipher Medicine , a developer of a molecular technology platform used to ensure patients are prescribed the most effective therapy, announced an investment from Optum Ventures, the independent venture fund of Optum. Under the terms of the agreement, Optum Ventures has made an equity investment in Scipher Medicine to acc

Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome, today announced that John McHutchison, AO, MD, Chief Executive Officer and President will present at the 9th Annual SVB Leerink Global Healthcare Conference